Reference
Yann K, et al. Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders 14: 1-3, May 2017. Available from: URL: http://doi.org/10.1016/j.msard.2017.03.001 - United Kingdom
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1648, 22 (2017). https://doi.org/10.1007/s40278-017-29001-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-29001-2